Sartorius Aktiengesellschaft (FRA:SRT3)

Germany · Delayed Price · Currency is EUR · Preferred Stock

210.20

+0.04 (0.02%)

At close: Mar 27, 2026

-4.45% (1Y)

Market Cap	12.99B -7.4%
Revenue (ttm)	3.54B +4.7%
Net Income	154.90M +84.4%
EPS	2.24 +84.2%
Shares Out	n/a
PE Ratio	83.83
Forward PE	34.40
Dividend	0.74 (0.37%)
Ex-Dividend Date	Mar 27, 2026

Volume	113
Average Volume	235
Open	214.00
Previous Close	210.16
Day's Range	210.20 - 214.00
52-Week Range	169.45 - 266.00
Beta	n/a
RSI	40.93
Earnings Date	Apr 23, 2026

About FRA:SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture... [Read more]

Industry Laboratory Analytical Instruments

Founded 1870

Employees 13,671

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol SRT3